Evidence map›Paper›PMID 26041963›Full record

ReviewJournal of clinical and experimental hepatology2015

Management of covert hepatic encephalopathy.

Abhijeet Waghray, Nisheet Waghray, Kevin Mullen

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of clinical and experimental hepatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Probiotics for people with hepatic encephalopathy.The Cochrane database of systematic reviews · 2017
    Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Hepatobiliary Quiz (Answers)-14 (2015).Journal of clinical and experimental hepatology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Abhijeet WaghrayDepartment of Medicine, MetroHealth Medical Center/Case Western Reserve University, 2500 MetroHealth Drive, Cleveland, OH 44109, USA.
Nisheet WaghrayDivision of Gastroenterology, MetroHealth Medical Center/Case Western Reserve University, 2500 MetroHealth Drive, Cleveland, OH 44109, USA.
Kevin MullenDivision of Gastroenterology, MetroHealth Medical Center/Case Western Reserve University, 2500 MetroHealth Drive, Cleveland, OH 44109, USA.
MetroHealth Medical Center · USCase Western Reserve University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatic encephalopathy is a reversible progressive neuropsychiatric disorder that encompasses a wide clinical spectrum. Covert hepatic encephalopathy is defined as patients with minimal hepatic encephalopathy and Grade I encephalopathy by West-Haven Criteria. Terminology such as "sub-clinical", "latent", and "minimal" appear to trivialize the disease and have been replaced by the term covert. The lack of clinical signs means that covert hepatic encephalopathy is rarely recognized or treated outside of clinical trials with options for therapy based on patients with episodic hepatic encephalopathy. This review discusses the current available options for therapy in covert hepatic encephalopathy and focuses on non-absorbable disacharides (lactulose or lactitol), antibiotics (rifaximin), probiotics/synbiotics and l-ornithine-l-aspartate.

Indexed as

APT, abnormal psychometric testingBAEP, brain auditory evoked potentialBDT, block design testCFF, critical flicker frequencyDST, digit symbol testFCT-A, Figure connection test-AFOS, fructo-oligosaccharideshepatic encephalopathyHRQoL, health-related quality of lifeICT, inhibitory control testlactuloseLCT, line tracing testNCT-A, number connection tests ANCT-B, number connection tests BNPE, neuropsychological examOCTT, orocecal transit timePCT, Picture completion testprobioticsPSE, psychometric testingRCT, race track testrifaximinSDMT, Symbol digit modalities testSDT, serial-dotting testSPT, standard psychometric testTMT, Trail making test

Identifiers

PMID26041963
PMCPMC4442854
OpenAlexW2100055771

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.